An expert committee convened by the US Food and Drug Administration (USFDA) voted heavily in favor of recommending the Pfizer-BioNTech Covid-19 vaccine for emergency use approval on Thursday. The...
Health
With 31 thousand 5 hundred 22 new COVID-19 infections in 24 hours, India’s total cases reached 97 lakh 67 thousand 3 hundred 72. The Health Ministry said, 412 people...
With 32 thousand and 80 new COVID-19 infections, India’s total cases have gone up to 97 lakh 35 thousand 850. The Health Ministry said, 402 people lost their lives...
Health
Top Stories
Will launch world’s biggest COVID-19 vaccination drive with help of mobile technology: PM
Prime Minister Narendra Modi has stressed on the need to work together to ensure timely roll-out of next generation 5G technology to leapfrog into the future and empower millions...
India has crossed a significant milestone in its fight against COVID. The national cumulative recovery rate has also further improved to 94.59 per cent with recovery of nearly 91...
Business and Commerce
Health
Top Stories
Bharat Biotech applies for emergency use authorisation for its indigenous Corona vaccine
Bharat Biotech, developer of indigenous COVID-19 vaccine, COVAXIN has applied to the central drug regulator, DCGI, seeking emergency use authorisation for its vaccine. With this, the Hyderabad based firm,...
Health
Top Stories
After Pfizer, Serum Institute of India seeks approval for COVID-19 vaccine: media
The media on Monday citing their information from their sources reported that Serum Institute of India, the world’s largest vaccine maker by number of doses produced, has sought government...
India has leaped across a significant milestone in its fight against COVID-19. The number of new daily cases have been below the 50 thousand mark for 25 consecutive days....
In a historic move, Britain has become the first country in the world to approve the Pfizer-BioNTech coronavirus vaccine. They have said that the vaccine will be rolled out...
Health
Top Stories
Serum Institute of India to apply for emergency authorisation of COVID-19 vaccine in next two weeks
Serum Institute of India (SII) will apply for emergency authorisation of COVID-19 vaccine in next two weeks. This was stated by the chief executive of the Institute, Adar Poonawalla...